These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21341458)

  • 1. [Chronic cerebrovascular diseases, metabolic syndrome and the status of hemorrheological and hemostatic systems].
    Tanashian MM; Ionova VG; Orlov SV; Omel'chenko NG; Shabalina AA; Kostyreva MV
    Ter Arkh; 2010; 82(10):19-24. PubMed ID: 21341458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemorheology and hemostasis in patients suffering from ischemic cerebral stroke and metabolic syndrome].
    Orlov SV; Domashenko MA; Kostyreva MV; Shabalina AA; Ionova VG; Tanashian MM
    Klin Med (Mosk); 2007; 85(1):40-4. PubMed ID: 17419354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of clinical features of cognitive impairment and depressive disorders in patients with metabolic syndrome with insufficiency of cerebral circulation].
    Kopchak OO
    Lik Sprava; 2013; (3):39-48. PubMed ID: 25016745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorheological disturbances in patients with chronic cerebrovascular diseases.
    Szapary L; Horvath B; Marton Z; Alexy T; Demeter N; Szots M; Klabuzai A; Kesmarky G; Juricskay I; Gaal V; Czopf J; Toth K
    Clin Hemorheol Microcirc; 2004; 31(1):1-9. PubMed ID: 15272148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
    Smyr KV; Shcherbak AV; Kozlovskaia LV; Sokolova IA; Bobkova IN; Podorol'skaia LV
    Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrovascular diseases: perspectives of pathogenetic metabolic haemangiocorrective treatment].
    Tanashyan MM; Lagoda OV; Antonova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9):70-75. PubMed ID: 26525819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A state of hemostasis in patients with arterial hypertension complicated with early forms of chronic cerebrovascular pathology].
    Stroeva VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):56-60. PubMed ID: 18833119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
    Ragab A; Abousamra NK; Higazy A; Saleh O
    Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative characteristics of hemostasis parameters and peripheral vascular regulation and hemodynamics in patients with Willebrand's disease and hematogenic thrombophilia].
    Vozniuk VP; Iushchenko PV
    Lik Sprava; 2010; (5-6):90-9. PubMed ID: 21488373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The correction of lipid peroxidation metabolism, the hemostatic system and cerebral hemodynamics in patients with the initial manifestations of cerebral circulatory insufficiency].
    Vesel'skiĭ ISh; Gritsaĭ NN
    Lik Sprava; 1992 Jul; (7):50-2. PubMed ID: 1448987
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of the fibrinolytic system and hemorheology with symptoms in patients with carotid occlusive disease.
    Soinne L; Saimanen E; Malmberg-Céder K; Kovanen P; Lindsberg PJ; Kaste M; Lassila R
    Cerebrovasc Dis; 2005; 20(3):172-9. PubMed ID: 16088112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between hemostatic variables, insulin resistance and inflammation.
    Morange PE; Alessi MC; Juhan-Vague I
    Hematol J; 2004; 5 Suppl 3():S15-9. PubMed ID: 15190271
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of the interferon system in pathogenesis of endothelial dysfunction in patients with metabolic syndrome].
    Voloshyna OO; Rybalko SL
    Lik Sprava; 2008; (5-6):24-8. PubMed ID: 19253735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An evaluation of the vascular factors of the hemostatic system during the rehabilitation of patients after cerebral circulatory disorders].
    Gorbunov FE; Kochetkov AV; Makarov VA; Tomilova IA; Vakulenko VM; Volkova LP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (4):18-22. PubMed ID: 2275099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transcranial dopplerography in chronic disorders of cerebral circulation].
    Nazinian AG; Shmidt TE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(8):35-9. PubMed ID: 11552632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelium in thrombosis and hemostasis.
    Wu KK; Thiagarajan P
    Annu Rev Med; 1996; 47():315-31. PubMed ID: 8712785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: the metabolic syndrome--a chronic cardiovascular inflammatory condition.
    Zambon A; Pauletto P; Crepaldi G
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():20-3. PubMed ID: 16225466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrovascular diseases and metabolic syndrome].
    Tanashian MM; Lagoda OV; Orlov SV; Telenkova NG; Maksiutkina LN; Petrukhina SIu
    Ter Arkh; 2013; 85(10):34-42. PubMed ID: 24437216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.